Showing results (371-380 of 420) with videos related to
Sort By:
Pageof 42
International Forum of Allergy & Rhinology|December 31, 2024
Type 2 biomarkers in olfactory cleft mucus correlate with SNOT-22 in chronic rhinosinusitis independent of nasal polyp statusNikita Chapurin, Zachary M Soler, Sofia Khan, et al.International Forum of Allergy & Rhinology|February 17, 2024
Health care disparities and chronic rhinosinusitis: Does neighborhood disadvantage impact outcomes in sinonasal disease?Amarbir S Gill, Benton Tullis, Jess C Mace, et al.Neuroscience Research|October 13, 2009
Negative symptoms of schizophrenia correlate with impairment on the University of Pennsylvania smell identification testKoko Ishizuka, Katsunori Tajinda, Carlo Colantuoni, et al.International Forum of Allergy & Rhinology|August 8, 2022
Work productivity and activity impairment in patients with chronic rhinosinusitis undergoing endoscopic sinus surgery-A prospective, multi-institutional studyVivek C Pandrangi, Jess C Mace, Jee-Hong Kim, et al.Surgical Infections|April 18, 2007
Tissue and fluid penetration of garenoxacin in surgical patientsCharles E Edmiston, Candace J Krepel, Gary R Seabrook, et al.Journal of Telemedicine and Telecare|March 13, 2023
Scoping review of telehealth use by Indigenous populations from Australia, Canada, New Zealand, and the United StatesDébora Petry Moecke, Travis Holyk, Madelaine Beckett, et al.The Cochrane Database of Systematic Reviews|July 21, 2025
Implementation interventions to promote healthcare professional uptake of evidence-based opioid prescribing for adults with acute non-cancer painJason A Wallis, Aili V Langford, Denise O'Connor, et al.International Forum of Allergy & Rhinology|August 11, 2023
All chronic rhinosinusitis endotype clusters demonstrate improvement in patient-reported and clinical outcome measures after endoscopic sinus surgeryNikita Chapurin, Rodney J Schlosser, Jorge Gutierrez, et al.The Journal of Antimicrobial Chemotherapy|September 28, 2005
Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patientsCharles E Edmiston, Candace J Krepel, Karen S Kehl, et al.Journal of the American Geriatrics Society|April 6, 2026
Understanding the Role of Communication in Deprescribing Behavior ChangeTerri R Fried, Danijela Gnjidic, Parag Goyal, et al.Pageof 42